Plain-English translation of NCT07043153 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying whether two measurements found in routine blood work — the albumin-to-globulin ratio and the prognostic nutritional index — can help doctors predict when lupus is becoming more active. If this approach works, doctors could use these simple, inexpensive blood tests to better monitor lupus patients and catch disease flares earlier.
Lupus can be unpredictable, and doctors currently lack a quick, affordable way to track whether the disease is getting worse. This study hopes to create an easier tool that uses basic nutritional markers already measured in blood work, so doctors can catch problems sooner and adjust treatment if needed.
You likely qualify if…
You likely don't qualify if…
You would visit the research center to have blood drawn, which the team will test for the two markers they are studying. Your blood results will be compared with your lupus symptoms and other lab tests to see if these markers can reliably predict disease activity. The study will enroll 200 participants total, including people with active lupus and healthy volunteers for comparison.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Egypt
Enrollment target
~200 participants
Started
August 2025
Primary completion
June 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Hala A Hamid, Master
Sohag University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.